Oslo Cancer Cluster is co-hosting the 4th CIMT Endeavour Workshop on Translating cancer science into products and companies. The Endevaour workshop is a part of the annual CIMT Meeting, which is Europe’s largest immuno-oncology meeting.
The concept of CIMT Endeavour is to organize and build-up a unique and focused education and networking platform that addresses the translation of cancer immunotherapies from preclinical proof of concept to products for patients.
CIMT Endeavour 2016 Program
08:00 – 08:10 Welcome Address
Björn-Philipp Kloke, CIMT
08:10 – 09:00 Session 1: Keynote
Lothar Germeroth, Juno Therapeutics
09:00 – 10:10 Session 2: From science to products – Change of perspectives
Chair: Andrea Schilz (Ci3), Jutta Heix (Oslo Cancer Cluster)
10 min + 25 min Csk overexpression makes T cell dummy
presented by Nadia Mensali, Oslo University Hospital-Radiumhospitalet
10 min + 25 min The HLA-associated phosphoproteome as a new target for immunotherapy against hepatocellular carcinoma
presented by Nico Büttner, Universitätsklinikum Freiburg
Expert Advice Panel:
Stefan Ries, Global Head External Innovation Discovery Oncology, Roche
Georg Schnappauf, Patent Lawyer, Zwicker Schnappauf & Partner
David Phillips, Partner, SR One Ltd.
10:10 – 10:45 Coffee Break
10:45 – 11:45 Session 3: Company Story/Successful Deal
Chair: Rainer Wessel, Ci3
25 + 5 min Corporate Venture Investing in Life Sciences
David Phillips, Partner, SR One Ltd
25 + 5 min Precision BioSciences: a 10-Year-Old Startup
Derek Jantz, Chairman and CSO, Precision BioSciences, Inc.
11:45 – 12:00 Closing Words
Cedrik M. Britten, CIMT